###begin article-title 0
Transcriptional Regulation of PP2A-Aalpha Is Mediated by Multiple Factors Including AP-2alpha, CREB, ETS-1, and SP-1
###end article-title 0
###begin p 1
Conceived and designed the experiments: HGC WJH MD JQ JZ YL DWL. Performed the experiments: HGC WJH MD JQ DY JPL LX LG. Analyzed the data: HGC WJH MD JQ DY JPL LX LG SL DWL. Contributed reagents/materials/analysis tools: SL JZ YL. Wrote the paper: DWL.
###end p 1
###begin p 2
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
Protein phosphatases-2A (PP-2A) is a major serine/threonine phosphatase and accounts for more than 50% serine/threonine phosphatase activity in eukaryotes. The holoenzyme of PP-2A consists of the scaffold A subunit, the catalytic C subunit and the regulatory B subunit. The scaffold subunits, PP2A-Aalpha/beta, provide a platform for both C and B subunits to bind, thus playing a crucial role in providing specific PP-2A activity. Mutation of the two genes encoding PP2A-Aalpha/beta leads to carcinogenesis and likely other human diseases. Regulation of these genes by various factors, both extracellular and intracellular, remains largely unknown. In the present study, we have conducted functional dissection of the promoter of the mouse PP2A-Aalpha gene. Our results demonstrate that the proximal promoter of the mouse PP2A-Aalpha gene contains numerous cis-elements for the binding of CREB, ETS-1, AP-2alpha, SP-1 besides the putative TFIIB binding site (BRE) and the downstream promoter element (DPE). Gel mobility shifting assays revealed that CREB, ETS-1, AP-2alpha, and SP-1 all bind to PP2A-Aalpha gene promoter. In vitro mutagenesis and reporter gene activity assays reveal that while SP-1 displays negative regulation, CREB, ETS-1 and AP-2Aalpha all positively regulate the promoter of the PP2A-Aalpha gene. ChIP assays further confirm that all the above transcription factors participate the regulation of PP2A-Aalpha gene promoter. Together, our results reveal that multiple transcription factors regulate the PP2A-Aalpha gene.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Olsen1">[1]</xref>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Olsen1">[1]</xref>
###xml 501 504 501 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Moorhead1">[6]</xref>
Protein phosphorylation and dephosphorylation are the most important regulatory mechanisms modulating functions of more than one third of the total cellular proteins [1]. Protein serine/threonine phosphatase 2A (PP-2A) is a major eukaryotic phosphatase, regulating many different functions including metabolism, DNA replication, transcription, RNA splicing, translation, cell cycle progression, cell senescence and apoptosis, cell transformation, morphogenesis, development, and neurotransmission [1]-[6].
###end p 4
###begin p 5
###xml 61 64 61 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Moorhead1">[6]</xref>
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Xu1">[7]</xref>
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Xu1">[7]</xref>
###xml 272 275 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Moorhead1">[6]</xref>
###xml 452 455 445 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Moorhead1">[6]</xref>
###xml 575 578 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Xu1">[7]</xref>
###xml 579 583 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Zheng1">[10]</xref>
PP-2A exists in both core enzyme and holoenzyme within cells [6]-[7]. The core enzyme consists of a 65 kDa scaffolding protein known as A subunit tethering a 36 kDa catalytic C subunit [7]. Both A and C subunits exist in alpha and beta isoforms encoded by different genes [6]. The full specific activity towards a certain substrate of PP-2A core enzyme is achieved through binding of a variable regulatory subunit to form the heterotrimeric holoenzyme [6]. So far, at least 16 genes have been identified encoding 4 subfamilies of the regulatory subunits: B, B', B'' and B''' [7]-[10].
###end p 5
###begin p 6
###xml 237 241 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Walter1">[11]</xref>
###xml 242 246 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Groves1">[13]</xref>
###xml 303 307 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger1">[14]</xref>
###xml 556 559 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Xu1">[7]</xref>
###xml 561 565 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger2">[15]</xref>
###xml 566 570 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Xing1">[16]</xref>
The scaffold subunit of PP-2A bears unique structure features. The 65 kDa protein (both alpha and beta isoforms) contains 15 tandem repeats with a conserved 39-residue sequence known as a Huntington-elongation-A subunit-TOR (HEAT) motif [11]-[13], which is organized into an extended, L-shaped molecule [14]. The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15, while the regulatory subunit contact the scaffold by interacting with the conserved HEAT repeats 1 to 10 [7], [15]-[16].
###end p 6
###begin p 7
###xml 392 396 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Janssens1">[17]</xref>
###xml 524 528 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Wang1">[18]</xref>
###xml 529 533 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger4">[22]</xref>
###xml 666 670 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Colella1">[23]</xref>
###xml 759 763 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Suzuki1">[24]</xref>
###xml 945 949 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Palczewski1">[25]</xref>
###xml 963 967 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Kantorow1">[26]</xref>
###xml 419 424 <span type="species:ncbi:9606">human</span>
The functional importance of the PP-2A scaffold subunit is derived from the two important observations. First, mutations in both alpha and beta isoforms of the scaffolding subunit result in compromised binding to the regulatory or catalytic subunit of PP-2A. As a result, the functional scaffold subunits are diminished or substantially reduced and the specific PP-2A activity is compromised [17]. A variety of primary human tumors including lung and colon cancers are associated with the mutations of the scaffold subunits [18]-[22]. Secondly, deregulation of the scaffold subunit expression leads to distinct downregulation of PP-2A activity, causing brain tumors [23]. A reduced expression of PP2A-Aalpha was also observed in the breast cancer cells MCF-7 [24]. In addition, changed expression of the scaffold subunits may contribute to altered activity of PP-2A, which is implicated in multiple ocular diseases including retina degeneration [25] and cataract [26].
###end p 7
###begin p 8
###xml 260 265 <span type="species:ncbi:10090">mouse</span>
At present, however, very little is known about the regulation of expression of the PP-2A scaffold subunits. To get insight into the regulation of PP2A-Aalpha/beta expression, we have cloned the promoter regions of the genes encoding the scaffold subunits for mouse PP-2A. Here, we report the functional dissection of the PP2A-Aalpha gene promoter through sequential deletion, in vitro mutagenesis, gel mobility shifting, reporter gene activity and ChIP assays. Our results demonstrate that numerous transcription factors including ETS-1, CREB, AP-2alpha and SP-1 regulate the PP2A-Aalpha gene promoter.
###end p 8
###begin title 9
Material and Methods
###end title 9
###begin title 10
Cell culture
###end title 10
###begin p 11
###xml 269 273 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Mao1">[27]</xref>
###xml 359 360 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 477 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Mao1">[27]</xref>
###xml 478 482 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 230 235 <span type="species:ncbi:9606">Human</span>
Embryonic human lens epithelial cells (FHL124 line) and mouse lens epithelial cells (alphaTN4-1) were kindly provided by Dr. John Reddan (Oakland University) and Dr. Paul Russell (University of California at Davis), respectively. Human retinal pigment epithelial cells [27] were obtained from ATCC. All cells were cultured in monolayers at 37degreesC and 5%CO2 in Eagle's MEM containing 10% FBS, 2 mM L-glutamine, and 1% penicillin and streptomycin as previously described [27]-[29].
###end p 11
###begin title 12
Molecular cloning of the PP2A-Aalpha promoter and creation of A1 to A6 deletion mutants
###end title 12
###begin p 13
###xml 177 181 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Liu1">[30]</xref>
###xml 208 215 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007019-t001">Table 1</xref>
###xml 570 574 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Li2">[31]</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:10090">mouse</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
The genomic DNAs used for cloning of the PP2A-Aalpha promoter were extracted from the muscle tissue of the adult mice. Isolation of the mouse muscle tissue was described before [30]. Seven different primers (Table 1) were designed for PCR reactions using mouse genomic DNA as template. The amplified mouse PP2A-Aalpha promoter (A1) or the truncated promoter fragments (A2 to A6) were separately inserted into pGL3-basic, a background luciferase reporter gene vector at Xho I and Hind III restriction sites using standard molecular cloning techniques as described before [31].
###end p 13
###begin title 14
OLIGO PRIMERS USED FOR CLONING OF PP2A-Aalpha PROMOTOR.
###end title 14
###begin p 15
###xml 76 88 76 88 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCGAGCTCGAG</named-content>
###xml 76 88 76 88 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><named-content content-type="gene">CTCGAGCTCGAG</named-content></underline>
###xml 105 117 105 117 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AAGCTTAAGCTT</underline>
###xml 103 117 103 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(-<underline>AAGCTTAAGCTT</underline></bold>
Note: For the convenience, two restriction enzyme recognition sites: Xho I (CTCGAGCTCGAG) and Hind III (-AAGCTTAAGCTT) sites were added to the Primer-F and Primer-R, respectively.
###end p 15
###begin title 16
Western Blot Analysis
###end title 16
###begin p 17
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Li3">[32]</xref>
###xml 759 763 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
###xml 765 769 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Li3">[32]</xref>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
###xml 575 581 <span type="species:ncbi:9986">rabbit</span>
###xml 594 598 <span type="species:ncbi:9925">goat</span>
Western blot analysis was conducted as previously described [32]. Total proteins were extracted from ARPE-19 and FHL124 cells. Fifty microg of total proteins were used for each lane of loaded sample. The protein blots were blocked with 5% milk in TBS buffer overnight at 4degreesC and then incubated for 1 h or overnight with antibodies against, PP2A-Aalpha, CREB and AP-2alpha (Cell Signaling Technology, MA), ETS-1 and SP-1 (Santa Cruz Biotechnology Inc, CA), and beta-actin antibody (Sigma, MO) at a dilution of 1:200-3000. The secondary antibody was anti-mouse IgG, anti-rabbit IgG or anti-goat IgG (Amersham Biosciences, Piscataway, NJ and Santa Cruz Biotechnology Inc, CA) at a dilution of 1:1000-3000. Immunoreactivity was detected as described before [29], [32].
###end p 17
###begin title 18
Gel Mobility Shifting Assays
###end title 18
###begin p 19
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Mao2">[33]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Qin1">[34]</xref>
###xml 111 140 111 140 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCCTTCATTACGTCACGCATAG-3&#8242;</named-content>
###xml 191 221 187 217 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCCTTCATTCATTCACGCATAG -3&#8242;</named-content>
###xml 253 281 249 277 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAGATACTTCACTTCCGGTTC-3&#8242;</named-content>
###xml 333 361 325 353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAGATACTTCACTCAAGGTTC-3&#8242;</named-content>
###xml 394 425 386 417 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TCCGCCTCTCCCCAAGGGGCCATC-3&#8242;</named-content>
###xml 485 516 469 500 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCCGCCTCTAAACAAGGGGCCATC-3&#8242;</named-content>
###xml 557 584 537 564 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGGCACCGCCCCGCCCGATC-3&#8242;</named-content>
###xml 642 669 618 645 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGGCACCGAACCGCCCGATC-3&#8242;</named-content>
###xml 813 814 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 822 824 790 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 935 939 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Qin1">[34]</xref>
###xml 1266 1267 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1275 1277 1233 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 430 435 <span type="species:ncbi:10090">mouse</span>
###xml 589 594 <span type="species:ncbi:10090">mouse</span>
Gel mobility shifting assays were conducted as previously described [33]-[34]. The following oligos were used: 5'-GTCCTTCATTACGTCACGCATAG-3' for mouse PP2A-Aalpha promoter CREB binding site, 5'-GTCCTTCATTCATTCACGCATAG -3' for mutated CREB binding site; 5'-TAAGATACTTCACTTCCGGTTC-3' for mouse PP2A-Aalpha promoter ETS-1 binding site, 5'-TAAGATACTTCACTCAAGGTTC-3' for mutated ETS-1 binding site; 5'- TCCGCCTCTCCCCAAGGGGCCATC-3' for mouse PP2A-Aalpha promoter AP-2alpha (1) binding site, 5'-CTCCGCCTCTAAACAAGGGGCCATC-3' for mutated AP-2alpha (1) binding site; 5'-CCGGCACCGCCCCGCCCGATC-3' for mouse PP2A-Aalpha promoter SP-1 & SP-3 binding site, 5'-CCGGCACCGAACCGCCCGATC-3' for mutated SP-1 & SP-3 binding site. Thirty microg of nuclear extracts prepared from ARPE, FHL124 or alphaTN4-1 cells were incubated with 1x105 cpm of 32P-labeled double-stranded synthetic oligonucleotides for 30 minutes at 37degreesC in a binding shifting buffer [34]. For competition experiments, 50-fold of the non-labeled wild type or mutant double-stranded synthetic oligonucleotides were pre-incubated with the nuclear extracts for 10 minutes before the labeled probe was added into the reaction. For the supershifting experiments, 30 microg of each nuclear extract was incubated with 1x105 cpm of 32P-labeled double-stranded synthetic oligonucleotides of each primer pair for 30 minutes at 37degreesC in a binding shifting buffer, then 10 microg antibody against CREB, ETS-1, AP-2alpha, SP-1, or SP-3 or normal IgG (mock) was incubated with the corresponding nuclear extract-primer complex for 45 minutes at room temperature. After the binding reactions, the mixtures were loaded onto 5% native PAGE and detected by autoradiography.
###end p 19
###begin title 20
Analysis of Transient Gene Expression
###end title 20
###begin p 21
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 219 224 <span type="species:ncbi:9606">human</span>
For reporter gene activity, 2 microg of A1 A2, A3, A4, A5 or A6 construct of the luciferase reporter gene and 20 ng internal control plasmid PhRL-sv40 were introduced into mouse alphaTN4-1 cells, human FHL124 cells, or human ARPE-19 cells in 12-well culture plates using lipofectamine 2000. After 24 hours, the luciferase activities from each testing construct (A1 A2, A3, A4, A5 or A6) and also from the internal control plasmid were measured using dual-luciferase reporter assay system from Promega Inc. The relative luciferase activity was determined by dividing the luciferase activity from the testing construct by that from the control plasmid. For CREB, ETS-1, AP-2alpha, SP-1 and SP-3 dose-dependent responses, 2 microg PP2A-Aalpha-luc construct plasmid (A5), and 20 ng internal control plasmid plus 0 to 500 ng of pCMV-CREB, pCMV-ETS-1, pCMV-AP-2alpha, pCMV-SP-1 or pCMV-SP-3 plasmid were co-transfected into both ARPE-19 and FHL124 cells, the transfected cells were harvested after 24 hours and the harvested cell extracts were used for assay of luciferase activity as described above.
###end p 21
###begin title 22
Chromatin Immunoprecipitation (ChIP) Assays
###end title 22
###begin p 23
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Qin1">[34]</xref>
###xml 146 147 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1544 1573 1498 1527 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCCTTCATTACGTCACGCATAG-3&#8242;</named-content>
###xml 1683 1710 1633 1660 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGGTTCAGACCAAACAGACG-3&#8242;</named-content>
###xml 1722 1748 1672 1698 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCCCTGGCGTTTCTATCAG-3&#8242;</named-content>
###xml 55 60 <span type="species:ncbi:10090">Mouse</span>
ChIP assay was conducted as previously described [34]. Mouse lens epithelial cells (alphaTN4-1) were grown to 95% confluence. Approximately 2.0x107 cells were incubated with 1% formaldehyde for 10 min at room temperature for cross-linking, which was terminated by washing the cells with 4 ml of 1.25 M glycine solution. The cells were further washed with cold PBS twice and then scraped into 1 ml of ChIP sonication buffer (50 mM Tris-HCl, pH 8.1, 1% Triton X-100, 0.1% sodium deoxycholate, 5 mM EDTA, and 150 mM NaCl) containing the protease inhibitor cocktail. These lysates were sonicated 20-25 times for 10 s each time to generate DNA fragments that ranged in size from 200 to 1000 bp. The sheared chromatin-lysed extracts were incubated with 5 microg of anti-CREB, anti-ETS-1, anti-SP-1 or anti-AP-2alpha antibody separately or 5 microg of normal IgG overnight at 4degreesC, and then incubated for an additional 1 h with 30 microl protein A/G agarose beads. The immunoprecipitates were washed with cold ChIP sonication buffer 3X and cold PBS 3X, then suspended in the elution buffer (Tris-EDTA buffer, pH 8.0 and 1% SDS), and incubated overnight at 65degreesC, and an additional 2 h at 55degreesC with 100 microg of protease K to reverse proteins/DNA cross-links. Finally, these samples were processed for DNA purification by phenol-chloroform extraction and ethanol precipitation. PCRs were performed in 25 microl with 1/500 of input DNA or 1/100 of the immunoprecipitates with two pairs of primers: one for ETS-1 and CREB binding sites, 5'-GTCCTTCATTACGTCACGCATAG-3' (forward), 5'-GAACCGGAAGTGAAGTATC-TTA -3' (reverse); and the other for the AP-2alpha and SP-1 binding sites, 5'- TGGTTCAGACCAAACAGACG-3' (forward), 5'-CTCCCTGGCGTTTCTATCAG-3' (reverse); which generates DNA fragments of 189 bp and 168 bp, respectively. PCR was conducted with following specifications: 94degreesC 5 min, (94degreesC 30 s, 52degreesC 30 s, and 72degreesC 30 s)x30, 72degreesC 5 min, and the PCR products were separated on an 1.5% agarose gel and stained with ethidium bromide.
###end p 23
###begin title 24
Statistical Analysis
###end title 24
###begin p 25
All of the data presented are derived from at least three independent experiments. All the luciferase reporter gene activity data were subjected to statistical analysis. The means, S.D. and P values were calculated and included in the corresponding figures.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Isolation of the functional proximal PP2A-Aalpha promoter
###end title 27
###begin p 28
###xml 114 121 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1A</xref>
###xml 351 358 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1A</xref>
###xml 415 419 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Liu1">[30]</xref>
###xml 537 541 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Palczewski1">[25]</xref>
###xml 542 546 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Kantorow1">[26]</xref>
###xml 1076 1083 1064 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1B</xref>
###xml 1253 1260 1241 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1B</xref>
###xml 1443 1450 1431 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1B</xref>
###xml 1581 1588 1569 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g001">Fig. 1B</xref>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:9606">human</span>
To dissect the proximal promoter for the PP2A-Aalpha gene, we amplified six genomic fragments of different sizes (Fig. 1A). These fragments were subsequently inserted into a basic luciferase reporter gene construct, pGL3-basic (from Promega) at Xho I (5') and Hind III (3') sites to make 6 luciferase reporter gene constructs, designated as A1 to A6 (Fig. 1A). Because PP-2A plays vital roles in the ocular tissues [30] and changed PP-2A activity is implicated in multiple ocular diseases including retina degeneration and lens cataract [25]-[26], we used retina and lens cell lines as assay systems to characterize the PP2A-Aalpha promoter. When the 6 constructs were individually transfected into mouse lens epithelial cells, alphaTN4-1 and human lens epithelial cells, FHL124, luciferase reporter gene activity assays demonstrated that compared with the longest construct A1, a sequential deletion from 5' end of about 400 (A2) to 800 bp (A3) leads to about 40 to 50% enhancement of the luciferase activities, suggesting that a repressor element exists within this region (Fig. 1B). A deletion of additional 323 bp (A4) leads to further enhancement of the luciferase activity, indicating existence of additional repressor element within this region (Fig. 1B). Removal of 96 bp at 5' end from A4 fragment yields construct A5 and causes a 20% decrease in luciferase activity, suggesting the presence of a positive enhancer from -721 to -625 (Fig. 1B). A further deletion of 500 bp at 5' end from A5 fragment yielded construct A6, and caused a 80% drop of the luciferase activity (Fig. 1B). Since the luciferase activity driven by A5 is similar to that driven by A2 and A3 but drops significantly when driven by A6, we consider that the 677 bp PP2A-Aalpha promoter (-625 to +52) acts as the proximal promoter and was further examined in detail.
###end p 28
###begin title 29
Identification of the proximal PP2A-Aalpha promoter.
###end title 29
###begin p 30
###xml 224 231 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 298 305 290 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007019-t001">Table 1</xref>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
A. Diagrams of 6 different constructs of the PP2A-Aalpha promoter linked to the luciferase reporter gene. Genomic DNA was extracted from mouse muscle and used for PCR amplification of the PP2A-Aalpha promoter fragments (see methods for details). To identify the proximal promoter, 7 oligo primers (Table 1) were designed, synthesized and used for PCR. The amplified 6 DNA fragments were digested and then inserted into the basic luciferase reporter construct to generate A1 to A6 constructs. B. Relative luciferase activities derived from 6 different PP2A-Aalpha gene promoter constructs. Two microg of A1 A2, A3, A4, A5 or A6 construct of the luciferase reporter gene and 20 ng internal control plasmid PhRL-sv40 were introduced into mouse lens epithelial alphaTN4-1 cells (Open bars) and human lens epithelial FHL124 cells (solid bars) in 12-well culture plates using lipofectamine 2000. After 24 hours, the luciferase activities from each testing construct and also from the internal control plasmid were measured using dual-luciferase reporter assay system from Promega Inc. The relative luciferase activity was determined by dividing the luciferase activity from the testing construct by that from the control plasmid. The ratio of A1 activity is assumed as 100%, then the activity of each of the five constructs were calculated using A1 as reference. Note that the construct A5 displays similar luciferase activity to A3 and A4, suggesting that this construct contains the proximal promoter of the PP2A-Aalpha gene.
###end p 30
###begin title 31
###xml 61 64 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
The proximal PP2A-Aalpha promoter contains multiple putative cis-elements for CREB, ETS-1, AP-2alpha and SP-1
###end title 31
###begin p 32
###xml 218 221 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 307 314 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2A</xref>
###xml 494 501 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2A</xref>
###xml 956 963 932 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2B</xref>
###xml 1546 1551 1498 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1316 1321 <span type="species:ncbi:10090">mouse</span>
To characterize the PP2A-Aalpha gene promoter, we have analyzed the proximal promoter sequence using web software TFSEARCH (transcriptional factor search) and TESS (transcription element search system), and found four cis-elements with the highest scores for CREB, ETS-1, SP-1 and AP-2alpha in this region (Fig. 2A). The CREB binding site is found from -373 to -362, an ETS-1 binding site from -202 to -192, and two AP-2alpha binding sites from -321 to -312, and from -84 to -76, respectively (Fig. 2A). In addition, a SP-1 binding site is identified in the core promoter region from -17 to -6 of the PP2A-Aalpha gene. To explore if these elements might be functional in the ocular tissues, we first examined the association of the expressions of PP2A-Aalpha with that of the four transcription factors, CREB, ETS-1, SP-1 and AP-2alpha in the retinal pigmental epithelial cells (ARPE-19) and the embryonic lens epithelial cells (FHL124 cells). As shown in Fig. 2B, both cell lines contain relatively high levels of PP2A-Aalpha. Associated with the high level of PP2A-Aalpha expression, high levels of CREB and AP-2alpha expression are also detected in the two cell lines. In addition, fair levels of ETS-1 and SP-1 expression were also detected. Similar expression patterns of the above factors were observed in the mouse lens epithelial cells, alphaTN4-1 (data not shown). These results suggest that the four cis-elements, CREB, ETS-1, SP-1 and AP-2alpha in PP2A-Aalpha gene promoter are likely mediating transcription regulation by the cognate trans-factors in these ocular cell lines.
###end p 32
###begin title 33
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Identification of the major cis-elements in the proximal promoter of the PP2A-Aalpha gene.
###end title 33
###begin p 34
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 244 247 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
A. Identification of the four putative cis-elements: ETS-1, CREB, AP-2alpha and SP-1 in the proximal promoter of the PP2A-Aalpha gene. The 677 bp DNA sequence (from +52 to -625) was analyzed with TFSEARCH and TESS two softwares. Four conserved cis-elements (marked below the sequence) were discovered. In the core promoter region of the PP2A-Aalpha gene, a putative TFIIB recognition element (BRE) and a putative downstream promoter element (DPE) are observed. However, the core promoter of the PP2A-Aalpha gene lacks TATA-box. The transcription initiation site was assigned according to the reported results. B. Western blot analysis of PP2A-Aalpha and the four cognate transcriptional factors (ETS-1, CREB, AP-2alpha and SP-1) in two ocular cell lines, retinal epithelial cells (ARPE-19) and the embryonic lens epithelial cells (FHL124).
###end p 34
###begin title 35
ETS-1 interacts with the proximal promoter of PP2A-Aalpha and plays a fundamental role in PP2A-Aalpha regulation
###end title 35
###begin p 36
###xml 142 149 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3A</xref>
###xml 274 281 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 358 365 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 422 429 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 543 550 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 591 598 587 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 1198 1205 1178 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3C</xref>
###xml 1492 1499 1464 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3D</xref>
###xml 1874 1881 1838 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3E</xref>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:9606">human</span>
###xml 809 814 <span type="species:ncbi:10090">mouse</span>
###xml 895 900 <span type="species:ncbi:10090">mouse</span>
###xml 2067 2072 <span type="species:ncbi:9606">human</span>
###xml 2077 2082 <span type="species:ncbi:10090">mouse</span>
To demonstrate if ETS-1 regulates PP2A-Aalpha, we have conducted gel mobility shifting assay with an oligo containing the ETS-1 binding site (Fig. 3A), nuclear extracts from human ARPE-19 cells or from human FHL124 cells showed a strong binding to ETS-1 oligo (lane 1, 6 of Fig. 3B), this binding can be competed off by the cold ETS-1 oligo (lane 2 and 7 of Fig. 3B) but only slightly by the mutant oligo (lane 3 and 8 of Fig. 3B). The DNA-ETS-1 complex can be recognized by anti-ETS-1 antibody to form supershifting complex (lane 5 and 10 of Fig. 3B) but not by normal IgG (lane 4 and 9 of Fig. 3B). These results suggest that human ETS-1 could regulate mouse PP2A-Aalpha gene promoter in both ARPE-19 cells and FHL124 cells, and that the PP2A-Aalpha promoter may be functionally conserved between human and mouse. Similar binding pattern was observed with ETS-1 oligo and nuclear extract from mouse alphaTN4-1 cells (data not shown). To further confirm the ETS-1 control on PP2A-Aalpha gene, we mutated the ETS-1 binding site and examined the relative luciferase activities from the two constructs with either wild type or mutant ETS-1 binding sites in both ARPE-19 and FHL124 cells. As shown in Fig. 3C, mutation of the ETS-1 binding site led to about 60% decrease in the PP2A-Aalpha promoter activity as assayed in both types of cells. Next, we co-transfected the luciferase reporter gene driven by the PP2A-Aalpha proximal promoter and the exogenous ETS-1 expression vector. As shown in Fig. 3D, expression of the exogenous ETS-1 (0 to 100 ng) induced a dose-dependent increase in the luciferase activity in both ARPE-19 cells and FHL124 cells. Mutation of the ETS-1 binding site in the PP2A-Aalpha promoter abolished this dose-dependent response (data not shown). Further more, expression of the exogenous ETS-1 also enhanced expression of the endogenous PP2A-Aalpha (Fig. 3E). Together, these results demonstrate that ETS-1 can regulate PP2A-Aalpha and this regulation is very important. In addition, the PP2A-Aalpha promoter is functionally conserved between human and mouse.
###end p 36
###begin title 37
Demonstration that ETS-1 regulates the PP2A-Aalpha promoter.
###end title 37
###begin p 38
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3B</xref>
###xml 344 346 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 988 995 984 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3A</xref>
###xml 2574 2578 2558 2562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
A. Wild type or mutant ETS-1 oligos used for gel mobility shifting assays described in Fig. 3B. B. Gel mobility shifting demonstrates that ETS-1 from both ARPE-19 (Lane 1 to 5) and FHL124 (Lane 6 to 10) binds to the oligo containing the wild type ETS-1 binding site. Nuclear extracts prepared from both types of cells were incubated with gamma-32P-ATP-labeled oligos containing wild-type ETS-1 binding site under various conditions shown in the figure. The reaction mixtures were then separated with 5% native PAGE. The gel was dried and exposed to X-ray film for overnight. Lane 1, gel mobility shifting assays with labeled oligo containing wild-type ETS-1 binding site and ARPE-19 nuclear extract. Lane 2, the same assay as in lane 1 except that 50-fold of non-labeled wild-type ETS-1 oligos was added into the reaction. Note that the ETS-1 complex was competed off. Lane 3, the same assay as in lane 1 except that the non-labeled competing oligo contains a mutated ETS-1 binding site (Fig. 3A, bottom), which showed only slight competition ability. Lane 4, the same assay as in lane 1 except that normal IgG was used for mock supershifting assay. Lane 5, the same assay as in lane 1 except that anti-ETS-1 antibody was added for supershifting assay. Note that addition of anti-ETS-1 antibody into the reaction led to formation of the supershifting ETS-1 complex. Lane 6 to Lane 10, the same order as in Lane 1 to Lane 5 except that the nuclear extracts were from the FHL124 cells. C to E. Demonstration of the relative importance of the ETS-1 binding site in regulating the PP2A-Aalpha promoter. C. Mutation of the ETS-1 binding site in the PP2A-Aalpha promoter causes an approximately 60% loss of the luciferase reporter gene activity in both types of ocular cells. The P value was calculated by comparing the activity difference between the mutant promoter with the wild type promoter in the same type of cell. D. Expression of the exogenous ETS-1 in both types of ocular cells induces dose-dependent increase in the luciferase reporter gene activity within 0 to 500 ng of the pCMV-ETS-1 plasmid. The P value was calculated by comparing the luciferase difference between the vector (pCI-Neo) co-expression and the co-expression of each concentration of exogenous Ets-1 plasmid (50, 100 and 500 ng) with the wild type promoter in the same type of cell. E. Expression of the exogenous ETS-1 in both types of ocular cells enhanced expression of the endogenous gene coding for PP2A-Aalpha. Transfection and luciferase activity assays were conducted as previously described [29].
###end p 38
###begin title 39
CREB binds to the proximal promoter of PP2A-Aalpha and plays an important regulatory role in PP2A-Aalpha expression
###end title 39
###begin p 40
###xml 207 214 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4A</xref>
###xml 336 343 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 416 423 408 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 467 474 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 678 685 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 801 808 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 1255 1262 1235 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4C</xref>
###xml 1768 1775 1732 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4D</xref>
###xml 2255 2262 2211 2218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4E</xref>
###xml 889 894 <span type="species:ncbi:10090">mouse</span>
###xml 2452 2457 <span type="species:ncbi:9606">human</span>
###xml 2462 2467 <span type="species:ncbi:10090">mouse</span>
To determine if the CREB element can regulate PP2A-Aalpha promoter, we also conducted gel mobility shifting assay with an oligo primer containing the CREB binding site derived from the PP2A-Aalpha promoter (Fig. 4A). The nuclear extracts from either ARPE-19 cells or from FHL124 cells showed a strong binding to CREB site (lane 1, 6 of Fig. 4B), this binding can be competed off by the cold CREB oligo (lane 2, 7 of Fig. 4B) but not by the mutant oligo (lane 3, 8 of Fig. 4B). Addition of the anti-CREB antibody into the binding reactions between labeled CREB oligo and the nuclear extracts from both ARPE-19 and FHL124 cells induced obvious supershifting complex (lane 4, 9 of Fig. 4B). However, addition of normal IgG into the same reactions did not produce the supershifting complex (lane 5, 10 of Fig. 4B). Similar binding pattern was observed with CREB oligo and nuclear extract from mouse alphaTN4-1 cells (data not shown). These results suggest that CREB also regulates PP2A-Aalpha. To further confirm that CREB controls the PP2A-Aalpha gene promoter, we mutated the CREB binding site and compared the relative luciferase activity between the two constructs with wild type or mutant CREB binding sites in both ARPE-19 and FHL124 cells. As shown in Fig. 4C, mutation of the CREB binding site led to about 40% decrease in the PP2A-Aalpha promoter activity as assayed in both types of cells. Thus, reporter gene activity assays on wild type PP2A-Aalpha promoter and differentially mutated PP2A-Aalpha promoters reveal that ETS-1 and CREB display differential control over PP2A-Aalpha promoter. Next, we also conducted co-transfection analysis on the luciferase reporter gene activity driven by the A5 promoter with exogenous CREB expression construct. As shown in Fig. 4D, expression of the exogenous CREB (0 to 500 ng) induces a dose-dependent increase in the luciferase activity in both ARPE-19 cells and FHL124 cells. Moreover, the magnitude of induction is greater in FHL124 cells than in ARPE-19 cells. Mutation of the CREB site in the PP2A-Aalpha promoter abolished this dose-dependent response (data not shown). In addition, expression of the exogenous CREB also enhanced expression of the endogenous PP2A-Aalpha in both types of ocular cells (Fig. 4E). Together, these results show that CREB also plays an important role in regulating PP2A-Aalpha activity, and further demonstrate that the PP2A-Aalpha promoter is functionally conserved in human and mouse.
###end p 40
###begin title 41
Demonstration that CREB regulates the PP2A-Aalpha promoter.
###end title 41
###begin p 42
###xml 86 93 86 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4B</xref>
###xml 358 360 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 850 857 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">Fig. 4A</xref>
###xml 2458 2462 2442 2446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
A. Wild type or mutant CREB oligos used for gel mobility shifting assays described in Fig. 4B. B. Gel mobility shifting demonstrates that CREB from both ARPE-19 (Lane 1 to 5) and FHL124 (Lane 6 to 10) nuclear extracts binds to the oligo containing the wild type CREB binding site. Nuclear extracts prepared from both types of cells were incubated with gamma-32P-ATP-labeled oligos containing wild-type CREB binding site under various conditions shown in the figure. Lane 1, gel mobility shifting assay with labeled wild type CREB oligo and ARPE-19 nuclear extract. Lane 2, the same assay as in lane 1 except that 50-fold of wild-type CREB non-labeled oligos was added into the reaction. Note that the CREB complex was competed off. Lane 3, the same assay as in lane 1 except that the non-labeled competing oligo contains a mutated CREB binding site (Fig. 4A, bottom), which showed very little competition ability. Lane 4, the same assay as in lane 1 except that anti-CREB antibody was added into the reaction. Note that addition of anti-CREB antibody into the reaction led to formation of the supershifting CREB complex. Lane 5, the same assay as described in lane 1 except that normal IgG was added into the reaction to conduct mock supershifting assay. Lane 6 to Lane 10, the same order as in Lane 1 to Lane 5 except that the nuclear extracts were from the FHL124 cells. C. to E. Demonstration of the relative importance of the CREB binding site in regulating the PP2A-Aalpha promoter. C. Mutation of the CREB binding site in the PP2A-Aalpha promoter causes an approximately 40% loss of the luciferase reporter gene activity in both types of ocular cells. The P value was calculated by comparing the activity difference between the mutant promoter with the wild type promoter in the same type of cell. D. Expression of the exogenous CREB in both types of ocular cells induces dose-dependent increase in the luciferase reporter gene activity within 0 to 500 ng of the pCMV-CREB plasmid. The P value was calculated by comparing the luciferase difference between the vector (pCI-Neo) co-expression and the co-expression of each concentration of exogenous CREB plasmid (50, 100 and 500 ng) with the wild type promoter in the same type of cell. E. Expression of the exogenous CREB in both types of ocular cells enhanced expression of the endogenous gene coding for PP2A-Aalpha. Transfection and luciferase activity assays were conducted as previously described [29].
###end p 42
###begin title 43
AP-2alpha interacts with the proximal promoter of PP2A-Aalpha and exerts positive control
###end title 43
###begin p 44
###xml 167 174 155 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5A</xref>
###xml 305 312 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B</xref>
###xml 405 412 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B</xref>
###xml 467 477 447 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B, A</xref>
###xml 779 786 747 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B</xref>
###xml 874 881 842 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B</xref>
###xml 1284 1291 1220 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5A</xref>
###xml 1408 1415 1344 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5C</xref>
###xml 1924 1931 1840 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5C</xref>
###xml 2057 2064 1969 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5D</xref>
###xml 2486 2493 2378 2385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5E</xref>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
To test if AP-2alpha also regulates PP2A-Aalpha gene promoter, we again conducted gel mobility shifting assay with an oligo containing the AP-2alpha (1) binding site (Fig. 5A). The nuclear extracts from either ARPE-19 cells or from FHL124 cells showed a strong binding to AP-2alpha (1) site (lane 1, 6 of Fig. 5B), this binding can be completely competed off by the cold AP-2alpha (1) oligo (lane 2, 7 of Fig. 5B) but only partially by the mutant oligo {lane 3, 8 of Fig. 5B, A change of 3-nucleatide in the AP-2alpha (1) binding site only partially abolished the binding activity}. Addition of the anti-AP-2alpha antibody into the binding reactions between labeled AP-2alpha oligo and the nuclear extracts from the two types of cells induced a supershifting band (lane 5, 10 of Fig. 5B). This supershifting complex did not appear when the normal IgG was used (lane 4, 9 of Fig. 5B). Similar binding pattern was observed with AP-2alpha oligo and nuclear extract from mouse alphaTN4-1 cells (data not shown). These results suggest that AP-2alpha also regulates PP2A-Aalpha To further confirm the AP-2alpha control on PP2A-Aalpha gene promoter, we again mutated the two AP-2alpha binding sites either individually or in combination (the mutation of the two AP-2alpha sites are shown in Fig. 5A) and assayed the relative luciferase activity from the two constructs in both ARPE-19 and FHL124 cells. As shown in Fig. 5C, mutation of each AP-2alpha binding site led to 10 to 15% decrease in the PP2A-Aalpha promoter activity as assayed in both types of cells. Mutation of both AP-2alpha sites at the same time caused an approximately 20% decrease in the reporter gene activity. Statistical analysis revealed that the P value is less than 0.05 when each mutant promoter was compared with the wild type promoter. Thus, mutation of either AP-2alpha site causes statistically significant change in the PP2A-Aalpha promoter activity (Fig. 5C). Next, we examined the luciferase reporter gene activity in the presence of the exogenous AP-2alpha expression. As shown in Fig. 5D, expression of the exogenous AP-2alpha (0 to 500 ng) induced a dose-dependent increase in the luciferase activity in both ARPE-19 cells and FHL124 cells. Mutations of the two AP-2alpha binding sites in the PP2A-Aalpha promoter abolished this dose-dependent response (data not shown). In addition, expression of the exogenous AP-2alpha also enhanced expression of the endogenous PP2A-Aalpha in both types of ocular cells (Fig. 5E). Together, these results show that AP-2alpha displays a positive regulation on the PP2A-Aalpha promoter.
###end p 44
###begin title 45
Demonstration that AP-2alpha regulates the PP2A-Aalpha promoter.
###end title 45
###begin p 46
###xml 95 102 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5B</xref>
###xml 392 394 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1150 1157 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">Fig. 5A</xref>
###xml 2969 2973 2873 2877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
A. Wild type or mutant AP-2alpha (1) oligos used for gel mobility shifting assays described in Fig. 5B. B. Gel mobility shifting demonstrates that AP-2alpha from both ARPE-19 and FHL124 nuclear extracts binds to the oligo containing the wild type AP-2alpha (1) binding site. Nuclear extracts prepared from ARPE-19 cells (Lane 1 to 5) and FHL124 cells (Lane 6 to 10) were incubated with gamma-32P-ATP-labeled oligo-nucleotide containing wild-type AP-2alpha binding site under various conditions shown in the figure. The reaction mixtures were then separated with 5% native PAGE. The gel was dried and exposed to X-ray film for overnight. Lane 1, gel mobility shifting assays with labeled oligo containing wild-type AP-2alpha binding site and nuclear extract from ARPE-19 cells. Lane 2, the same assay as described for lane 1 except that 50-fold of non-labeled oligo containing the wild-type AP-2alpha binding site was added into the reaction. Note that the AP-2alpha complex was competed off by the non-labeled oligo. Lane 3, the same assay as described in lane 1 except that the non-labeled competing oligo contains a mutated AP-2alpha binding site (Fig. 5A, bottom), which showed much weaker competition ability. Lane 4, the same assay as described in lane 1 except that normal IgG was added into the reaction to conduct mock supershifting assay. Lane 5, the same assay as described in lane 1 except that anti-AP-2alpha antibody was added into the reaction. Note that addition of anti-AP-2alpha antibody into the reaction led to formation of the supershifting AP-2alpha complex. Lane 6 to Lane 10, the same order as in Lane 1 to Lane 5 except that the nuclear extracts were from the FHL124 cells. C. to E. Demonstration of the relative importance of the AP-2alpha binding site in the regulation of the PP2A-Aalpha promoter. C. Mutations of the AP-2alpha (1), AP-2alpha (2) or both AP-2alpha sites in the PP2A-Aalpha promoter cause approximately 10%, 15% and 18% reduction in the luciferase reporter gene activity, respectively. The P value was calculated by comparing the activity difference between each individual mutant promoter with the wild type promoter, or between the mutant promoter with both AP-2alpha sites mutated with the wild type promoter in the same type of cell. D. Expression of the exogenous AP-2alpha in both types of ocular cells induces dose-dependent increase in the luciferase reporter gene activity within 0 to 500 ng of the pCMV-AP-2alpha plasmid. The P value was calculated by comparing the luciferase difference between the vector (pCI-Neo) co-expression and the co-expression of each concentration of exogenous AP-2alpha plasmid (50, 100 and 500 ng) with the wild type promoter in the same type of cell. E. Expression of the exogenous AP-2alpha in both types of ocular cells only slightly enhanced expression of the endogenous gene coding for PP2A-Aalpha. Transfection and luciferase activity assays were conducted as previously described [29].
###end p 46
###begin title 47
The interaction between SP-1/SP-3 and the proximal promoter of PP2A-Aalpha leads to negative regulation
###end title 47
###begin p 48
###xml 174 181 166 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6A</xref>
###xml 289 296 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 353 360 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 509 516 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 555 562 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 602 609 594 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 700 707 692 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 749 756 741 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 795 802 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 1469 1476 1445 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6C</xref>
###xml 1840 1847 1812 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6C</xref>
###xml 2021 2028 1993 2000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6D</xref>
###xml 2060 2067 2032 2039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6F</xref>
###xml 2082 2089 2054 2061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6D</xref>
###xml 2777 2784 2741 2748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6E</xref>
###xml 2929 2936 2889 2896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6G</xref>
###xml 1031 1036 <span type="species:ncbi:10090">mouse</span>
To elucidate if SP-1/SP-3 regulates PP2A-Aalpha promoter, we also conducted gel mobility shifting assay with an oligo containing the SP-1/SP-3 binding site from PP2A-Aalpha (Fig. 6A). The nuclear extract from ARPE-19 cells displayed a relatively weak binding to SP-1/SP-3 oligo (lane 2 of Fig. 6B) compared with the extract from FHL124 cells (lane 7 of Fig. 6B). Nevertheless, this binding is specific in both types of cells because it can be completely competed off by the cold SP-1/SP-3 oligo (lane 1, 8 of Fig. 6B) but much less competition (lane 9 of Fig. 6B) or very little competition (lane 3 of Fig. 6B) was observed with the mutant oligo. Addition of the anti-SP-1 antibody (lane 5 and 11 of Fig. 6B) or anti-SP-3 antibody (lane 6 and 12 of Fig. 6B) but not normal IgG (lane 4 and 10 of Fig. 6B) into the binding reactions between labeled SP-1/SP-3 oligo and the nuclear extracts from the two types of cells induced the supershifting band. Similar binding pattern was observed with SP-1/SP-3 oligo and nuclear extract from mouse alphaTN4-1 cells (data not shown). These results suggest that SP-1/SP-3 also regulates PP2A-Aalpha gene. To determine the nature of the SP-1/SP-3 regulation on PP2A-Aalpha gene, we mutated the SP-1/SP-3 binding site within the core promoter of PP2A-Aalpha, and compared the relative luciferase activity between the two constructs with either wild type or mutant SP-1/SP-3 binding sites in both ARPE-19 and FHL124 cells. As shown in Fig. 6C, mutation of the SP-1/SP-3 binding site led to 17 to 18% increase in the PP2A-Aalpha promoter activity as assayed in both types of cells. The P value for this difference is less than 0.015 when the mutant promoter was compared with the wild type promoter in the same type of cell assayed. Thus, mutation of SP-1/SP-3 site causes statistically significant change (Fig. 6C). To confirm this negative regulation, we also conducted co-transfection analysis of the luciferase reporter gene activity in the presence of the exogenous SP-1 expression (Fig. 6D) or exogenous SP-3 expression (Fig. 6F). As shown in Fig. 6D, expression of the exogenous SP-1 induces a dose-dependent decrease in the luciferase activity in both ARPE-19 cells and FHL124 cells, and this down-regulation is statistically significant (P<0.001). Mutation of the SP-1 site in the PP2A-Aalpha promoter abolished this dose-dependent response (data not shown). On the other hand, expression of the exogenous SP-3 induced a slight decrease in the luciferase activity in both ARPE-19 cells and FHL124 cells, which is not statistically significant since the P value is larger than 0.05. In addition, expression of the exogenous SP-1 led to some down-regulation in the expression of the endogenous PP2A-Aalpha in both types of ocular cells (Fig. 6E). But expression of the exogenous SP-3 caused very little change in the expression of the endogenous PP2A-Aalpha in both types of ocular cells (Fig. 6G). Thus, different from ETS-1 CREB and AP-2alpha, SP-1 exerts negative control over PP2A-Aalpha promoter and SP-3 displays some negative effect which is not statistically significant.
###end p 48
###begin title 49
Demonstration that SP-1 and SP-3 negatively regulates the PP2A-Aalpha promoter.
###end title 49
###begin p 50
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 384 386 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1198 1205 1194 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6A</xref>
###xml 4197 4201 4177 4181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yan2">[29]</xref>
A. Wild type or mutant SP-1/SP-3 oligos used for gel mobility shifting assays described in Fig. 6B. B. Gel mobility shifting demonstrates that SP-1/SP-3 from both ARPE-19 and FHL124 nuclear extracts binds to the oligo containing the wild type SP-1/SP-3 binding site. Nuclear extracts prepared from ARPE-19 cells (Lane 1 to 6) and FHL124 cells (Lane 7 to 12) were incubated with gamma-32P-ATP-labeled oligo-nucleotide containing wild-type SP-1/SP-3 binding site under various conditions shown in the figure. The reaction mixtures were then separated with 5% native PAGE. The gel was dried and exposed to X-ray film for overnight. Lane 1, gel mobility shifting assays with labeled oligo containing wild-type SP-1/SP-3 binding site and nuclear extract from ARPE-19 cells and 50-fold of non-labeled oligo containing the wild-type SP-1/SP-3 binding site. Note that the SP-1/SP-3 complex was competed off by the non-labeled oligo. Lane 2, gel mobility shifting assays with labeled oligo containing wild-type SP-1/SP-3 binding site and nuclear extract from ARPE-19 cells. Lane 3, the same assay as described in lane 2 except that the non-labeled competing oligo contains a mutated SP-1/SP-3 binding site (Fig. 6A, bottom), which showed much weaker competition ability. Lane 4, the same assay as described in lane 2 except that normal IgG was added into the reaction to conduct mock supershifting assay. Note that addition of normal IgG interferes with the formation of the SP-1/SP-3 complex but did not change the mobility. Lane 5, the same assay as described in lane 2 except that anti-SP-1 antibody was added into the reaction. Note that addition of anti-SP-1 antibody into the reaction led to formation of the supershifting SP-1 complex. Lane 6, the same assay as described in lane 2 except that anti-SP-3 antibody was added into the reaction. Note that addition of anti-SP-3 antibody into the reaction also led to formation of the supershifting SP-3 complex. Lane 7, gel mobility shifting assays with labeled oligo containing wild-type SP-1/SP-3 binding site and nuclear extract from FHL124 cells; Lane 8, the same as lane 7 except that 50-fold of non-labeled oligo containing the wild-type SP-1/SP-3 binding site was added into the reaction. Note that the SP-1/SP-3 complex was completely competed off by the non-labeled oligo. Lane 9 to Lane 12, the same order as in Lane 3 to Lane 6 except that the nuclear extracts were from the FHL124 cells. C to G. Demonstration of the relative importance of the SP-1/SP-3 binding site in the regulation of the PP2A-Aalpha promoter. C. Mutation of the SP-1/SP-3 binding site in the PP2A-Aalpha promoter causes an approximately 17 to 18% enhancement of the luciferase reporter gene activity in both types of ocular cells. The P value was calculated by comparing the activity difference between the mutant promoter with the wild type promoter in the same type of cell. D. Expression of the exogenous SP-1 in both types of ocular cells induces dose-dependent decrease in the luciferase reporter gene activity within 0 to 500 ng of the pCMV-SP-1 plasmid. The P value was calculated by comparing the luciferase difference between the vector (pCI-Neo) co-expression and the co-expression of each concentration of exogenous SP-1 plasmid (50, 100 and 500 ng) with the wild type promoter in the same type of cell. E. Expression of the exogenous pCMV-SP-1 in both types of ocular cells attenuated expression of the endogenous gene coding for PP2A-Aalpha. F. Expression of the exogenous SP-3 in both types of ocular cells induced only slight decrease in the luciferase reporter gene activity within 0 to 500 ng of the pCMV-SP-3 plasmid, which is not statistically significant. The P value was calculated by comparing the luciferase difference between the vector (pCI-Neo) co-expression and the co-expression of each concentration of exogenous SP-3 plasmid (50, 100 and 500 ng) with the wild type promoter in the same type of cell. G. Expression of the exogenous pCMV-SP-3 in both types of ocular cells caused little change in the expression of the endogenous gene coding for PP2A-Aalpha. Transfection and luciferase activity assays were conducted as previously described [29].
###end p 50
###begin title 51
ChIP assays reveal that ETS-1, CREB, AP-2alpha and SP-1 all binds to PP2A-Aalpha promoter
###end title 51
###begin p 52
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 171 175 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Qin1">[34]</xref>
###xml 581 588 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g007">Fig. 7A</xref>
###xml 614 621 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g007">Fig. 7B</xref>
###xml 787 801 759 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g007">Fig. 7A and 7B</xref>
###xml 974 988 946 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g007">Fig. 7A and 7B</xref>
###xml 1027 1030 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
To further confirm that the four cis-elements found in the proximal promoter of PP2A-Aalpha were functional in vivo, we conducted ChIP assays using mouse alphaTN4-1 cells [34]. In these cells, a high level of PP2A-Aalpha expression was also detected (data not shown). When the endogenous PP2A-Aalpha gene chromatin from alphaTN4-1 cells were randomly fragmented through sonication, antibody against ETS-1, CREB, SP-1 or AP-2alpha used for immunoprecipitation was able to precipitate down the PP2A-Aalpha proximal promoter sequences which can be amplified into 189 bp (lane 2, 4 of Fig. 7A) or 168 bp (lane 2, 4 of Fig. 7B) fragment after PCR reaction. As a comparison, the immunoprecipitated products using normal IgG did not contain the PP2A-Aalpha promoter DNA sequences (lane 3, 5 of Fig. 7A and 7B). As positive controls, the isolated genomic DNA input was directly used for PCR analysis and the corresponding 189 bp and 168 bp fragments were also identified (lane 6 of Fig. 7A and 7B). These results suggest that the four cis-elements identified in the PP2A-Aalpha promoter play important roles in mediating transcriptional regulation by the corresponding transcriptional factors.
###end p 52
###begin title 53
ChIP assays to demonstrate that ETS-1, CREB, AP-2alpha and SP-1 bind to PP-2alpha promoter.
###end title 53
###begin p 54
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Qin1">[34]</xref>
###xml 108 129 108 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
ChIP assays were conducted as we recently described [34]. The oligos used for ChIP assays were described in Materials and Methods. A. ChIP assays to show that ETS-1 and CREB bind to PP-2Aalpha promoter. Lane 1, DNA marker; lane 2, PCR product derived from 1/50 DNA template immunoprecipitated by anti-CREB antibody; Lane 3, PCR product derived from DNA template immunoprecipitated by normal IgG; lane 4, PCR product derived from 1/50 DNA template immunoprecipitated by anti-ETS-1 antibody; Lane 5, PCR product derived from DNA template immunoprecipitated by normal IgG; lane 6, PCR product derived from direct input DNA template without immunoprecipitation. A band of 189 bp containing both CREB and ETS-1 binding sites in the PP2A-Aalpha promoter gene was amplified. ChIP assay confirms that CREB and ETS-1 bind to PP2A-Aalpha gene. B. ChIP assays to show that AP-2alpha and SP-1 bind to PP-2Aalpha promoter. Lane 1, DNA marker; lane 2, PCR product derived from 1/50 DNA template immunoprecipitated by anti-SP-1 antibody; Lane 3, PCR product derived from DNA template immunoprecipitated by normal IgG; lane 4, PCR product derived from 1/50 DNA template immunoprecipitated by anti-AP-2alpha antibody; Lane 5, PCR product derived from DNA template immunoprecipitated by normal IgG; lane 6, PCR product derived from direct input DNA template without immunoprecipitation. A band of 168 bp containing both AP-2alpha and SP-1 binding sites in the PP2A-Aalpha promoter gene was amplified. ChIP assays confirm that AP-2alpha and SP-1 bind to PP2A-Aalpha gene.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 309 312 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 515 518 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1515 1518 1463 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1696 1702 1644 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g008">Fig. 8</xref>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 649 654 <span type="species:ncbi:9606">human</span>
###xml 659 664 <span type="species:ncbi:10090">mouse</span>
###xml 860 865 <span type="species:ncbi:9606">human</span>
###xml 1127 1132 <span type="species:ncbi:9606">human</span>
In the present study, we have conducted functional dissection of the PP2A-Aalpha gene promoter and obtained the following results: 1) Sequential deletion and luciferase reporter gene activity assays revealed that the mouse proximal promoter of PP2A-Aalpha consists of about 680 bp DNA fragment; 2) Four major cis-elements for ETS-1, CREB, AP-2alpha and SP-1/SP-3 are present in the proximal promoter; 3) DNA binding assays demonstrate that human ETS-1, CREB, AP-2alpha, SP-1 and SP-3 bind to the corresponding four cis-elements within the mouse proximal promoter of PP2A-Aalpha, and the proximal promoter of PP2A-Aalpha is functionally conserved in human and mouse; 4) In vitro mutagenesis and luciferase reporter gene activity assays demonstrate that ETS-1, CREB, and AP-2alpha act as enhancers and SP-1 and SP-3 as repressors on PP2A-Aalpha promoter in both human retinal pigment epithelial cells and lens epithelial cells; 5) Expression of exogenous ETS-1, CREB, AP-2alpha, or SP-1 induced dose-dependent responses of the luciferase reporter gene activity and also similarly regulates the endogenous gene for PP2A-Aalpha in human retinal pigmental epithelial cells and embryonic lens epithelial cells. Mutation of the corresponding cis-element eliminated the related dose-dependent response; 6). ChIP assays revealed that ETS-1, CREB, AP-2alpha or SP-1 all bind to the proximal promoter of PP2A-Aalpha. Together, our results have demonstrated that the proximal promoter of PP2A-Aalpha is regulated by four major cis-elements through interactions with their cognate transcriptional factors besides the basic core promoter elements mediating interactions with the general transcription factors (Fig. 8).
###end p 56
###begin title 57
Summary of the PP2A-Aalpha promoter.
###end title 57
###begin p 58
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
A. Relative importance of various cis-elements in the PP2A-Aalpha promoter as demonstrated by the differential reporter gene activities driven by wild type or various mutant PP2A-Aalpha promoter. 1: The wild type PP2A-Aalpha core promoter containing BRE, DPE, AP-2alpha (2) and the SP-1 binding site (A6); 2: The wild type PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites (A5); 3: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with CREB binding site mutated; 4: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with AP-2alpha(1) binding site mutated; 5: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with ETS-1 binding site mutated; 6: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with AP-2alpha(2) binding site mutated; 7: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with SP-1 binding site mutated; 8: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with AP-2alpha(1) and AP-2alpha(2) binding sites mutated; 9: The PP2A-Aalpha proximal promoter containing CREB, ETS-1, AP-2alpha(1), AP-2alpha (2), BRE, DPE and SP-1 binding sites with CREB and ETS-1 binding sites mutated. B. Diagram to show the relative positions of the cis-elements for general transcriptional factors and also the four major cis-elements for the cognate transcription factors in the PP2A-Aalpha proximal promoter.
###end p 58
###begin title 59
The proximal promoter of PP2A-Aalpha consists of BRE, DPE, and multiple enhancer elements but lack TATA element
###end title 59
###begin p 60
###xml 109 112 109 112 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B r</underline>
###xml 123 124 123 124 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</underline>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Butler1">[35]</xref>
###xml 517 524 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2A</xref>
###xml 731 735 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Burke1">[36]</xref>
###xml 736 740 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Zhou1">[39]</xref>
###xml 805 809 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Lagrange1">[40]</xref>
###xml 810 814 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Tsai1">[41]</xref>
###xml 1185 1199 1177 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6C and 6D</xref>
###xml 1259 1263 1251 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Dynan1">[42]</xref>
###xml 1265 1277 1257 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 1633 1639 1617 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6</xref>
###xml 1642 1654 1626 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
Previous studies of different eukaryotic gene promoters reveal that a typical core promoter contains the TFIIB recognition element {BRE element (GGGCGCC)} at -37 to -26, the TATA box (TATAAA) at -31 to -26, the initiator (PyPyANT/ApyPy) at -2 to +4, and the downstream promoter element {DPE element (A/GGA/TC/TG/A/C)} at +28 to +32 [35]. Examination of the core promoter for PP2A-Aalpha reveals the presence of the putative BRE element (GGGCGCC) at the -55 to -49, and the putative DPE element (TGATA) at +28 to +32 (Fig. 2A). The PP2A-Aalpha promoter, however, lacks the typical TATA box. The presence of the putative DPE element allows the binding of the general transcriptional factor, TFIID as found in most TATA-less promoter [36]-[39]. Moreover, the putative BRE element allows the binding of TFIIB [40]-[41]. In the core promoter, an additional element, the SP-1/SP-3 binding site, was identified from -6 to -18. The binding of SP-1/SP-3 to this region of the promoter likely interferes with the binding of the general transcription factors. Indeed, in vitro mutagenesis and luciferase reporter gene activity assays revealed that this SP-1 binding site exerts negative control (Fig. 6C and 6D), which is different from its action in other target genes [42]. Introduction of the exogenous SP-1 expression vector into both retinal pigment epithelial cells and lens epithelial cells induces dose-dependent decrease of the PP2A-Aalpha promoter activity and also downregulates expression of the endogenous PP2A-Aalpha gene in these cells, further confirming that the SP-1 binding site within the core promoter acts as a repressor (Fig. 6). Introduction of the exogenous SP-3 expression vector into the two types of cells also lead to negative control, which seems not statistically significant.
###end p 60
###begin p 61
###xml 75 78 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 285 292 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2A</xref>
###xml 429 433 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Pufall1">[43]</xref>
###xml 434 438 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Eckert1">[46]</xref>
###xml 599 602 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 635 638 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 664 672 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 945 952 929 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3C</xref>
###xml 957 959 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">4C</xref>
###xml 1130 1137 1110 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g008">Fig. 8A</xref>
###xml 1391 1398 1359 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g002">Fig. 2A</xref>
###xml 1678 1685 1638 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Fig. 6B</xref>
###xml 1868 1876 1816 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g006">Figs. 6C</xref>
###xml 1881 1883 1829 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g008">8A</xref>
###xml 2161 2168 2105 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3D</xref>
###xml 2170 2172 2114 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">4D</xref>
###xml 2177 2179 2121 2123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">5D</xref>
###xml 2315 2322 2255 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g003">Fig. 3E</xref>
###xml 2324 2326 2264 2266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g004">4E</xref>
###xml 2332 2334 2272 2274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g005">5E</xref>
###xml 2418 2421 2358 2361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 2530 2536 2466 2472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007019-g007">Fig. 7</xref>
###xml 2746 2750 2678 2682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Butler1">[35]</xref>
###xml 2849 2854 2777 2782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1923 1928 <span type="species:ncbi:9606">human</span>
Outside of the core promoter of the PP2A-Aalpha gene, three well-conserved cis-elements are identified: one ETS-1 binding site localized from -202 to -192, one CREB binding site found from -373 to -362, and two AP-2alpha binding sites localized from -321 to -312, and from -84 to -76 (Fig. 2A). Depending on the target genes and interacting partners, CREB, ETS-1 and AP-2alpha may act as either positive regulators or repressors [43]-[46]. In our study, gel mobility shifting assays with nuclear extracts from ARPE-19 or FHL124 cells reveal that both ETS-1 and CREB can strongly bind to the cognate cis-elements, indicating that these cis-elements are functional. In vitro mutagenesis and reporter gene assays demonstrate that both ETS-1 and CREB binding sites in the proximal promoter of the PP2A-Aalpha play very important role. Mutations of the ETS-1 and CREB sites individually lead to a loss of 58% and 43% promoter activity, respectively (Fig. 3C and 4C). Mutation of both sites at the same time causes additional lose of the proximal PP2A-Aalpha promoter, suggesting that both ETS-1 and CREB have some synergistic effects (Fig. 8A). Besides the ETS-1 and CREB binding sites, there are two copies of AP-2alpha binding sites in the proximal promoter. The AP-2alpha (2) site localized between -84 to -76 is more conserved than the other AP-2alpha (1) site localized within -321 to -312 (Fig. 2A). Consistent with this conservation is the effect they displayed on the reporter gene activity. When mutated, the promoter with the mutant AP-2alpha (2) loses about 15% promoter activity. In contrast, mutation of the AP-2alpha (1) causes about 10% lose in the promoter activity (Fig. 6B). Mutation of both AP-2alpha sites leads to a total of 18% loss in the PP2A-Aalpha promoter activity, also indicating the partial synergistic action between the two AP-2alpha sites (Figs. 6C and 8A). In both retinal epithelial cells and human lens epithelial cells, the enhancement of transcription by ETS-1, CREB, and AP-2alpha was further confirmed by the co-transfection study in which a dose-dependent response of the reporter gene activity was observed for each factor (Fig. 3D, 4D and 5D). Moreover, expression of each exogenous transcription factor also displays similar mode of action to the endogenous PP2A-Aalpha gene (Fig. 3E, 4E, and 5E). Thus, in vitro mutagenesis and co-transfection assays demonstrate that all three cis-elements act as enhancers in the PP2A-Aalpha promoter. This conclusion is further confirmed by ChIP assays (Fig. 7). Together, our results demonstrate that the PP2A-Aalpha promoter, though lacking the TATA box, contains the putative BRE and DPE elements mediating the basic regulation by the general transcriptional factors [35] and the enhancer elements (ETS, CREB and AP-2alpha) mediating the advanced control by the cognate trans-factors.
###end p 61
###begin title 62
PP2A-Aalpha/beta Plays A Critical Role in the Assembly of the Functional PP-2A
###end title 62
###begin p 63
###xml 179 182 179 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Moorhead1">[6]</xref>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Wang1">[18]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger4">[22]</xref>
As a major eukaryotic phosphatase, the normal function of PP-2A is essential in maintaining the organism homeostasis and preventing various pathological conditions such as cancer [6], [18]-[22]. PP-2A exists as either a heterodimeric core enzyme including the scaffold A subunit and catalytic C subunit, or a heterotrimeric holoenzyme consisting of the core enzyme plus one of the regulatory B subunits, thus providing temporal and spatial specificity of PP-2A activity within tissue cells of different organisms.
###end p 63
###begin p 64
###xml 493 497 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Walter2">[47]</xref>
###xml 498 502 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Janssens2">[48]</xref>
###xml 530 534 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Yang1">[49]</xref>
###xml 535 539 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Chen1">[50]</xref>
###xml 676 680 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Scheidtmann1">[51]</xref>
###xml 698 702 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger5">[52]</xref>
###xml 918 922 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Sontag1">[53]</xref>
###xml 958 962 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Hahn1">[54]</xref>
###xml 430 434 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Since both C and B subunits bind to the A subunit, the normal function of the scaffold A subunit plays a critical role in the assembly of either core enzyme or holoenzyme of PP-2A to govern its specific activity. This conclusion is derived from numerous studies. First, interruption of the function of the scaffold subunit by the small t antigen inhibits PP2A activity. The virus-encoded small t antigen (ST) of DNA tumor viruses SV40 and polyomavirus can exclusively bind to PP2A-Aalpha/beta [47]-[48] in the HEAT repeats 3 to 6 [49]-[50]. As a result of this binding, the phosphatase activity of the PP-2A core enzyme, but not the holoenzyme, was inhibited by the t antigen [51]. Reudiger et al. [52] have shown that varying the ratio of PP-2A core enzyme to holoenzyme causes significant biological consequence. Binding of the t antigen to PP2A-Aalpha/beta stimulates MAPK activation and induces cell proliferation [53] and eventually cell transformation [54].
###end p 64
###begin p 65
###xml 99 103 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Calin1">[19]</xref>
###xml 350 354 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger4">[22]</xref>
Second, mutations in the gene encoding PP2A-Aalpha leads to abolished PP-2A activity. Calin et al. [19] described four cancer-associated mutations in the PP2A-Aalpha gene: Glu64-Asp in lung carcinoma, Glu64-Gly in breast carcinoma, Arg418-Trp in melanoma, and a deletion mutant missing residue 171 to residue 589 in breast carcinoma. Reudiger et al. [22] have shown that these mutations greatly interrupt the interactions of the scaffold subunit with either B subunit alone (Glu64-Asp and Glu64-Gly), or with both B and C subunits (Arg418-Trp, and the deletion mutant), thus abolishing specific PP-2A activity and leading to tumor formation.
###end p 65
###begin p 66
###xml 215 219 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Ruediger4">[22]</xref>
###xml 357 361 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Colella1">[23]</xref>
###xml 586 590 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Colella1">[23]</xref>
###xml 791 794 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 884 887 857 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1010 1014 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Colella1">[23]</xref>
###xml 1298 1302 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Kitange1">[55]</xref>
###xml 1441 1445 1406 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Fleischman1">[56]</xref>
###xml 1562 1566 1523 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007019-Suzuki1">[24]</xref>
###xml 255 263 <span type="species:ncbi:9606">patients</span>
In addition, the normal expression level of PP2A-Aalpha gene plays an essential role in the assembly of functional PP-2A. It has been shown that both A and C subunits are expressed in similar levels in normal cells [22]. However, in about 43% brain tumor patients (Gliomas), PP-2A activity was significantly lower than that found in the normal brain tissue [23]. This decrease in PP-2A activity is neither derived from changed expression of the catalytic subunit of PP-2A nor from mutations of the PP2A-Aalpha/beta subunits but a 10-fold downregulation in the expression of PP2A-Aalpha [23]. What accounts for the downregulation of PP2A-Aalpha in these brain tumors remains to be further explored. Nevertheless, our demonstrations that the proximal promoter of PP2A-Aalpha contains multiple cis-elements including the binding sites for ETS-1, CREB, AP-2alpha and SP-1, and that these cis-elements are all functional provide some clues. The downregulated expression of the PP2A-Aalpha gene found in the gliomas [23] may be derived from the changed expression levels and functions of the related transcription factors. In this regard, it is worth to mention that ETS-1 is closely involved in gliomas development. ETS-1 protein is not only differentially expressed in astrocytes and astrocytoma cells [55] but also regulates various targets such as Egr-1, cathepsin B and the urokinase-type plasminogen activator besides PP2A-Aalpha in gliomas [56]. A reduced expression of PP2A-Aalpha has also been observed in other cancer cells such as breast cancer MCF-7 cells [24] and prostate cancer cells (Li et al. unpublished data). Our preliminary studies suggest the reduced PP2A-Aalpha expression is derived from changed expression levels of one or more transcription factors.
###end p 66
###begin p 67
###xml 378 383 <span type="species:ncbi:9606">human</span>
In summary, our characterization of the PP2A-Aalpha promoter lays a foundation for the further exploration on why PP2A-Aalpha is differentially expressed in the different types of cancers. Elucidation of the regulatory mechanisms governing PP2A-Aalpha expression will contribute fundamental knowledge to the understanding of the PP-2A functions in carcinogenesis and also other human diseases.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
###end article-title 69
###begin article-title 70
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.
###end article-title 70
###begin article-title 71
The structure and regulation of protein phosphatases:
###end article-title 71
###begin article-title 72
Protein serine/threonine phosphatases in the nerve system.
###end article-title 72
###begin article-title 73
Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth.
###end article-title 73
###begin article-title 74
Emerging roles of nuclear protein phosphatases.
###end article-title 74
###begin article-title 75
Structure of the protein phosphatase 2A holoenzyme.
###end article-title 75
###begin article-title 76
###xml 4 12 <span type="species:ncbi:7957">goldfish</span>
The goldfish SG2NA gene encodes two alpha-type regulatory subunits for PP-2A and displays distinct developmental expression pattern.
###end article-title 76
###begin article-title 77
###xml 101 109 <span type="species:ncbi:7957">goldfish</span>
###xml 111 128 <span type="species:ncbi:7957">carassius auratus</span>
Molecular cloning and differential expression patterns of the regulatory subunit B' gene of PP-2A in goldfish, carassius auratus.
###end article-title 77
###begin article-title 78
cDNA cloning and mRNA expression patterns of the alpha and gamma regulatory subunits of the PP2A-B'' family.
###end article-title 78
###begin article-title 79
Molecular cloning and sequence of cDNA encoding polyoma medium tumor antigen-associated 61-kDa protein.
###end article-title 79
###begin article-title 80
Alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure.
###end article-title 80
###begin article-title 81
The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs.
###end article-title 81
###begin article-title 82
###xml 140 155 <span type="species:ncbi:10633">simian virus 40</span>
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus.
###end article-title 82
###begin article-title 83
Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens.
###end article-title 83
###begin article-title 84
Structure of Protein Phosphatase 2A Core Enzyme Bound to Tumor-inducing Toxins.
###end article-title 84
###begin article-title 85
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
###end article-title 85
###begin article-title 86
###xml 35 40 <span type="species:ncbi:9606">human</span>
Alterations of the PPP2R1B gene in human lung and colon cancer.
###end article-title 86
###begin article-title 87
###xml 139 144 <span type="species:ncbi:9606">human</span>
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
###end article-title 87
###begin article-title 88
###xml 52 57 <span type="species:ncbi:9606">human</span>
Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.
###end article-title 88
###begin article-title 89
###xml 61 66 <span type="species:ncbi:9606">human</span>
Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene.
###end article-title 89
###begin article-title 90
###xml 60 65 <span type="species:ncbi:9606">human</span>
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.
###end article-title 90
###begin article-title 91
###xml 70 75 <span type="species:ncbi:9606">human</span>
Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genes.
###end article-title 91
###begin article-title 92
###xml 93 98 <span type="species:ncbi:9606">human</span>
Reduced expression of the regulatory A subunit of serine/threonine protein phosphatase 2A in human breast cancer MCF-7 cells.
###end article-title 92
###begin article-title 93
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Elevated level of protein phosphatase 2A activity in retinas of rd mice.
###end article-title 93
###begin article-title 94
###xml 84 89 <span type="species:ncbi:9606">human</span>
Differential display detects altered gene expression between cataractous and normal human lenses.
###end article-title 94
###begin article-title 95
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human alphaA- and alphaB-Crystallins bind to Bax and Bcl-XS to sequester their translocation during staurosporine-induced apoptosis.
###end article-title 95
###begin article-title 96
Protein Serine/Threonine Phosphatase-1 Dephosphorylates p53 at Ser-15 and Ser-37 to Modulate its Transcriptional and Apoptotic Activities.
###end article-title 96
###begin article-title 97
Protein Phosphatase-1 dephosphorylates Pax-6, a transcription factor controlling brain and eye development.
###end article-title 97
###begin article-title 98
###xml 110 115 <span type="species:ncbi:10090">Mouse</span>
Differential Expression of the Catalytic Subunits for PP-1 and PP-2A and the Regulatory Subunits for PP-2A in Mouse Eye.
###end article-title 98
###begin article-title 99
###xml 96 109 96 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Manduca sexta</italic>
###xml 78 94 <span type="species:ncbi:7130">tobacco hornworm</span>
###xml 96 109 <span type="species:ncbi:7130">Manduca sexta</span>
Two distinct genes encode two major isoelectric forms of insecticyanin in the tobacco hornworm, Manduca sexta.
###end article-title 99
###begin article-title 100
Calcium-Activated RAF/MEK/ERK pathway mediates p53-dependent apoptosis and is abrogated by alphaB-crystallin through Inhibition of Ras Activation.
###end article-title 100
###begin article-title 101
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 43 49 <span type="species:ncbi:9986">rabbit</span>
Human Bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation the alpha B crystallin gene.
###end article-title 101
###begin article-title 102
Protein phosphatase-2A is a target of epigallocatechin-3-gallate and regulates p53-Bak apoptotic pathway.
###end article-title 102
###begin article-title 103
The RNA polymerase II core promoter: a key component in the regulation of gene expression.
###end article-title 103
###begin article-title 104
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters.
###end article-title 104
###begin article-title 105
###xml 61 71 61 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 114 124 114 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 61 71 <span type="species:ncbi:7227">Drosophila</span>
###xml 75 81 <span type="species:ncbi:9606">humans</span>
###xml 114 124 <span type="species:ncbi:7227">Drosophila</span>
The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila.
###end article-title 105
###begin article-title 106
The DPE, a conserved downstream core promoter element that is functionally analogous to the TATA box.
###end article-title 106
###begin article-title 107
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAFII55</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
The intronless and TATAless human TAFII55 gene contains a functional initiator and a downstream promoter element.
###end article-title 107
###begin article-title 108
New core promoter element in RNA polymerase II-dependent transcription: Sequence-specific DNA binding by transcription factor IIB.
###end article-title 108
###begin article-title 109
###xml 54 59 <span type="species:ncbi:9606">human</span>
Structural basis of preinitiation complex assembly on human Pol II promoters.
###end article-title 109
###begin article-title 110
###xml 83 87 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The promoter-specific transcription factor SP-1 binds to upstream sequences in the SV40 early promoter.
###end article-title 110
###begin article-title 111
Variable control of ETS-1 DNA binding by multiple phosphates in an unstructured region.
###end article-title 111
###begin article-title 112
Transcriptional regulation by the phosphorylation dependent factor CREB.
###end article-title 112
###begin article-title 113
Phosphorylation represses ETS-1 DNA by reinforcing autoinhibition.
###end article-title 113
###begin article-title 114
The AP-2 family of transcription factors.
###end article-title 114
###begin article-title 115
Protein serine/threonine phosphatases and cell transformation.
###end article-title 115
###begin article-title 116
PP2A: the expected tumor suppressor.
###end article-title 116
###begin article-title 117
###xml 37 52 <span type="species:ncbi:10633">simian virus 40</span>
Control of protein phosphatase 2A by simian virus 40 small-t antigen.
###end article-title 117
###begin article-title 118
Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV 40.
###end article-title 118
###begin article-title 119
###xml 21 36 <span type="species:ncbi:10633">simian virus 40</span>
Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen.
###end article-title 119
###begin article-title 120
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.
###end article-title 120
###begin article-title 121
###xml 19 23 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation.
###end article-title 121
###begin article-title 122
###xml 19 34 <span type="species:ncbi:10633">simian virus 40</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Enumeration of the simian virus 40 early region elements necessary for human cell transformation.
###end article-title 122
###begin article-title 123
###xml 74 79 <span type="species:ncbi:9606">human</span>
Expression of ETS-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
###end article-title 123
###begin article-title 124
ETS-1 in astrocytes: expression and transmitter-evoked phosphorylation.
###end article-title 124
###begin p 125
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 125
###begin p 126
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study is supported in part by the National Institutes of Health Grants (1R01EY015765 and 1R01EY018380 to DWL), the University of Nebraska Medical Center start-up funds (DWL), the Lotus Scholar Professorship Funds from Hunan Province Government and Hunan Normal University (DWL), and the Changjiang Scholar Team Award from the National Education Ministry of China (JZ, SPL, YL and DWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 126

